Skip to main content

February 12, 2018, Meeting (on-line)

Tick-Borne Disease Working Group
February 12, 2018, Meeting (on-line)

Back to Tick-Borne Disease Working Group Meetings

February 12, 2018

TIMEAGENDA ITEMSPEAKER
Noon – 12:05 pm  Call to Order and WelcomeJohn Aucott, Kristen Honey, and Rich Wolitski 
12:05 pm -12:10 pm  Recap of Meetings One and Two
  Purpose and Goals of Today’s meeting
John
12:10 pm – 12:20 pm  Report to Congress and the HHS Secretary: OverviewRich
12:20 pm – 12:40 pm  Vote: Mission/Vision/Values of the TBDWGKristen
12:40 pm – 12:55 pm  Report on the Internal HHS Staff TBDWG
    - Anna Perea, CDC Division of Vector-Borne Disease
Anna Perea
12:55 pm – 1:10 pm  Report on One State’s Experience: What was learned in Virginia – example of a successful collaboration  
    - Michael Farris, JD, LLM, President, CEO and General Council Alliance Defending Freedom
Michael Farris
1:10 pm – 1:30 pm  Review of roles and tasks of subcommittees and subcommittee members, including Town HallJohn, Kristen, and Rich
1:30 pm – 2:00 pm  Public Comment Operator Assisted
2:00 pm - 2:05 pm  Break/Transition to Subcommittee Sessions 
2:05 pm – 3:05 pm

  Individual Subcommittees Meet---Members of the public are welcome to observe

    1. Introductions

    2. Inventory of Federal Actions
        a, Does anything need to be changed or added this year to address important subcommittee issues?

    3. Town Hall
        a. What are the 2-3 key issues that the subcommittee would like to receive input in the form of public comment?

Subcommittee Co-Chairs
3:05 pm – 3:10 pm  Break to allow transition back to main webinar 
3:10 pm – 3:40 pm  Subcommittees Report BackJohn and Kristen
Subcommittee Co-Chairs 
3:40 pm - 4:00 pm  Meeting Recap and Next StepsJohn and Kristen

Federal Register Meeting Announcement

Meeting Summary

Meeting Transcript

- Breakout Session Transcripts

Archived Webcast

Slide Presentations - PDF
Breakout Slides for Subcommittees - PDF

Written Public Comments

Transcript of Verbal Comments


Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
Content last reviewed April 7, 2022